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The acute phase of Mediterranean spotted fever (MSF) is characterized by dramatic changes in cytokine
production patterns, clearly indicating their role in the immunomodulation of the response against the
microorganism, and the differences in cytokine production seem to influence the extent and severity of the
disease. In this study, the single nucleotide polymorphisms (SNPs) of tumor necrosis factor alpha (TNF-)
308G/A (rs1800629) and interleukin-10 (IL-10) 1087G/A (rs1800896), 824C/T (rs1800871), and 597C/A
(rs1800872) and the gamma interferon (IFN-) T/A SNP at position874 (rs2430561) were typed in 80 Sicilian
patients affected by MSF and in 288 control subjects matched for age, gender, and geographic origin. No
significant differences in TNF- 308G/A genotype frequencies were observed. The 874TT genotype, asso-
ciated with an increased production of IFN-, was found to be significantly less frequent in MSF patients than
in the control group (odds ratio [OR], 0.18; 95% confidence interval [95% CI], 0.06 to 0.51; P corrected for the
number of genotypes [Pc], 0.0021). In addition, when evaluating the IFN- and IL-10 genotype interaction, a
significant increase of 874AA/597CA (OR, 5.31; 95% CI, 2.37 to 11.88; Pc, 0.0027) combined genotypes was
observed. In conclusion, our data strongly suggest that finely genetically tuned cytokine production may play
a crucial role in the regulation of the immune response against rickettsial infection, therefore influencing the
disease outcomes, ranging from nonapparent or subclinical condition to overt or fatal disease.
Several studies have demonstrated that cellular immunity
plays a critical role in the protective immune response against
Rickettsia conorii. Immune CD4 and CD8 T cells are both
involved in the control of rickettsial infection (38). Perivascular
infiltrated CD4 and CD8 T lymphocytes, macrophages, and
natural killer cells produce chemokines and cytokines that acti-
vate endothelial rickettsicidal activities. Infected human cells, in-
cluding endothelial cells, hepatocytes, and macrophages, acti-
vated by gamma interferon (IFN-), tumor necrosis factor alpha
(TNF-), and interleukin-1 (IL-1), kill intracellular rickettsiae
by one or a combination of three mechanisms, involving nitric
oxide synthesis, hydrogen peroxide production, and tryptophan
degradation (17). Moreover, clearance of rickettsiae requires
activated cytotoxic CD8 T cells, which eliminate the remain-
ing infected cells by inducing apoptosis (26, 41, 42).
The acute phase of Mediterranean spotted fever (MSF) is
characterized by significantly increased serum levels of IFN-,
TNF-, IL-10, and IL-6 compared to the levels found during
the convalescent phase of the disease or in healthy controls
(10, 40). The IFN- levels sharply drop within the second week
of the disease, whereas TNF-, IL-10, and IL-6 gradually de-
crease, reaching normal levels after the third week of infection
(40). The dramatic changes in the cytokine production pattern
clearly indicate their role in the immunomodulation of the
response against the microorganism, and differences in cyto-
kine production seem to influence the extent and severity of
the disease (26). On the other hand, the degree of cytokine
expression depends not only on the type and intensity of the
stimulation but also on host genetic factors, such as polymor-
phisms located in coding and regulatory regions of cytokine
genes (6). Cytokine single nucleotide polymorphisms (SNPs)
are important potential tools for genetic prediction of disease
susceptibility (22). This genetic variability might be responsible
for different rates of susceptibility to infectious diseases or
rates of development of severe complications (28). Associa-
tions of TNF- and/or IL-10 gene polymorphisms with cere-
bral malaria, mucocutaneous leishmaniasis, lepromatous lep-
rosy, and increased mortality for meningococcus meningitides
have been reported by different groups (1, 9, 19, 30, 39). Sim-
ilar results have been obtained for IL-1 gene cluster (5, 21) and
IFN- (25, 31) polymorphisms in studies of genetic suscepti-
bility to tuberculosis.
In the present study, we aimed at genotyping the SNPs of the
promoter regions of TNF- 308G/A (rs1800629) and IL-10
1087G/A (rs1800896), 824C/T (rs1800871), and 597C/A
(rs1800872) and the IFN- T/A SNP at position 874
(rs2430561) in a group of Sicilian patients affected by MSF,
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taking into account the role that these cytokines might play in
the immune response against R. conorii infection (26).
MATERIALS AND METHODS
Subjects. Eighty Sicilian patients affected by Rickettsia conorii infection (43
females and 37 males, with ages ranging from 30 to 60 years [mean age, 47 14])
were included in the study. The initial diagnosis of MSF was based on medical
history (history of tick exposure, outdoor activities, and animal contact), clinical
picture (fever, headache, maculopapular rash, and tache noire), and laboratory
results (leukopenia, thrombocytopenia, and elevated levels of hepatic enzymes).
The diagnosis was confirmed on the basis of detection of anti-R. conorii anti-
bodies by enzyme-linked immunosorbent assay and indirect immunofluorescence
assay and, when possible, by parasite isolation from the bone marrow aspirate
and/or from peripheral blood, as previously described (40). Two hundred eighty-
eight serum-negative healthy subjects (126 females and 162 males, with ages
ranging from 29 to 58 years [mean age, 45  9]) were included in the study.
Written informed consent for enrolling in the study and for personal data
management was obtained from all the subjects according to Italian laws. Blood
specimens from patients and control subjects were collected in tripotassium
EDTA sterile tubes, stored at 80°C, and then used for DNA extraction.
Molecular analysis of alleles at the 308 nucleotide (308G3A) of the
TNF- gene. The 308G/A polymorphism (rs1800629) of TNF- was identified
using a modification of the PCR-restriction fragment length polymorphism assay
described by Galbraith and Pandey (20). Briefly, 0.5 M of forward and reverse
primers (5 AGG CAA TAG GTT TTG AGG GCC AT 3 and 5 GGC GGG
GAT TTG GAA AGT T 3) were mixed with 5 to 10 ng of DNA template, with
a final concentration of 0.2 U Taq DNA polymerase (Perkin Elmer Biosystems,
Rome, Italy), 200 M of each deoxynucleotide, and 1	 reaction buffer. PCR was
performed for 35 cycles at 94°C, 58°C, and 72°C for 35 s each. Restriction enzyme
digestion with Ncol (M-Medical, Milan, Italy) of the PCR-amplified product (159
bp) and subsequent electrophoresis on a 2% to 5% agarose gel discriminated
between the two alleles:308A showed two fragments of 146 bp and 13 bp, while
308G was undigested and resulted in a single band of 159 bp. Heterozygous
individuals were detected by the presence of all three fragments.
Haplotype molecular analysis of alleles at the 1082 nucleotide of the IL-10
gene. Three different biallelic polymorphisms, rs1800896 (1087G/A), rs1800871
(824C/T), and rs1800872 (597C/A), of the IL-10 gene were identified using a
1082/819/592 haplotype-specific typing method (24), as previously de-
scribed (18). Briefly, 12 couples of 3 and 5 allele-specific sequence primer pairs
were separately mixed in a 13-l total volume containing 5 to 10 ng of DNA
template, 2.00 mM MgCl2, 9.8 mM ammonium sulfate, 39.6 mM Tris-HCl, 200
M deoxyribonucleotide triphosphates (dNTPs), and 0.2 U Taq-DNA polymer-
ase (Perkin Elmer Biosystems, Rome, Italy). Cycling was performed at 96°C for
1 min followed by 5 cycles at 96°C for 25 s, 70°C for 45 s, and 72°C for 45 s; 20
cycles at 96°C for 25 s, 65°C for 50 s, and 72°C for 45 s; and finally 5 cycles at 96°C
for 25 s, 55°C for 60 s, and 72°C for 120 s. PCR products, potentially containing
the 592/819, 592/1082, or 819/1082 possible allele combinations, were
detected by electrophoresis on 2% agarose.
Molecular analysis of alleles at the 874 nucleotide of the IFN- gene. The
874T/A polymorphism of IFN- (rs2430561) was typed using the amplification
refractory mutational system methodology described by Pravica et al. (32), as
previously described (25). Briefly, PCR products were obtained after amplifica-
tion in a 10-l total volume containing 1	 reaction buffer, 200 M (each) dNTP,
0.5 M each specific primer, 0.2 U of TaqGold-DNA polymerase (Perkin Elmer
Biosystems, Rome, Italy), and 5 to 10 ng of DNA template. Cycling was per-
formed at 95°C for 6 min, followed by 10 cycles at 96°C for 30 s, 60°C for 40 s,
and 72°C for 40 s, and finally 20 cycles at 96°C for 30 s, 56°C for 40 s, and 72°C
for 50 s. The amplified products were analyzed by electrophoresis on a 2%
agarose gel containing ethidium bromide (0.5 g/ml).
Statistical analysis. Cytokine polymorphisms and genotype frequencies were
evaluated by gene counts. The data were tested for the goodness of fit between
the observed and expected genotype frequencies (
2 test). When the observed
genotype frequencies fit to Hardy-Weinberg equilibrium, 
2 tests (3-by-2 or
2-by-2 tables; Graphpad Instat Package, Graphpad Software Inc., San Diego,
CA) were performed to calculate significantly different genotype distributions
between patients and controls. A nonparametric Mantel-Haenszel procedure
was applied for comparisons in which genotype frequencies of at least one group
did not fit to Hardy-Weinberg equilibrium. As multiple comparisons were made,
Bonferroni’s correction was applied to significant P values that were multiplied
for the number of genotypes detected (Pc).
RESULTS
In this study, the SNPs of TNF- 308G/A, of IL-10
1087G/A, 824C/T, and 597C/A, and of IFN- 874T/A
were typed in 80 patients affected by MSF and in 288 control
subjects matched for age, gender, and geographic origin. The
observed genotype frequencies were within the Hardy-Wein-
berg equilibrium, with the exception of IFN- genotype distri-
bution in the MSF patient group. No statistical differences
were observed for IL-10 1087G/A, 824C/T, or 592C/A or
for TNF- 308G/A between patients and controls (Table 1).
Since IL-10 824C/T and 597C/A SNPs are in complete
linkage disequilibrium (13), only data from the SNP at position
597 were included in the table. The analysis of IFN-
874T/A genotype frequencies by the nonparametric Mantel-
Haenszel procedure showed that significant differences existed
TABLE 1. Distribution of IL-10 (1087A/G and 597C/A), TNF- (308G/A), and IFN- (874T/A) SNP genotype frequencies in 80 MSF
patients and 288 healthy controls
SNP Genotypes
Patients Controls
OR (95% CI) P
n Frequency (%) n Frequency (%)
IL-10 1087G/A GG 17 21.2 67 23.3 0.89 (0.49–1.62) 0.82
GA 40 50.0 135 46.9 1.13 (0.69–1.86) 0.71
AA 23 28.8 86 29.9 0.95 (0.55–1.64) 0.96
IL-10 597C/A CC 43 53.8 152 52.8 1.04 (0.63–1.71) 0.98
CA 31 38.7 106 36.8 1.09 (0.65–1.81) 0.85
AA 6 7.5 30 10.4 0.70 (0.28–1.74) 0.57
TNF- 308G/A GG 60 75 209 72.6 1.13 (0.64–2.02) 0.77
GA 19 23.8 73 25.3 0.92 (0.51–1.64) 0.88
AA 1 1.2 6 2.1 0.60 (0.07–5.02) 0.98
IFN- 874T/Aa TT 4 5.0 65 22.6 0.18 (0.06–0.51) 0.0007
TA 51 63.8 154 53.5 1.53 (0.92–2.55) 0.13
AA 25 31.2 69 23.9 1.44 (0.84–2.50) 0.24
a The nonparametric Mantel-Haenszel procedure was applied for comparisons of IFN 874 genotype frequencies, as the MSF patient group did not fit to
Hardy-Weinberg equilibrium. As multiple comparisons were made, Bonferroni’s correction was applied to a significant P value that was multiplied by the number of
genotypes (three) detected (Pc  0.0021).
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in genotype frequencies between MSF patients and controls.
The 874TT genotype, associated with increased production
of IFN- (32, 33), was significantly less frequent in MSF pa-
tient than in the control group, and the P value after Bonfer-
roni’s correction (Pc) for the three genotypes detected was
0.0021 with an odds ratio (OR) of 0.18 and a 95% confidence
interval (95% CI) ranging between 0.06 and 0.51, suggesting
that the presence of the homozygous TT genotype might be
protective against MSF.
As previously reported (26, 40), IL-10 production during R.
conorii infection might counteract the IFN--mediated activa-
tion of intracellular microbicidal mechanisms. To evaluate if
interactions among genotypes that are able to influence IFN-
and IL-10 production are involved in MSF susceptibility or pro-
tection, the distribution in patients and controls of the 27 possible
IFN- and IL-10 (1087G/A, 824C/T, and 597C/A) SNP
combined genotypes were evaluated (Table 2). Again, only
data for SNPs at position 597 were included in the table. No
significant differences were observed among 874T/A/
1087A/G combined genotype frequencies of patients and
controls, whereas a significant increase of 874AA/597CA
(OR, 5.31; 95% CI, 2.37 to 11.88; Pc, 0.0027) combined geno-
types was observed. In addition, a roughly nonsignificant re-
duction of 874TT/597CC (OR, 0.08; 95% CI, 0.01 to 0.57;
Pc, 0.060) combined genotypes and an increase of 874TA/
597CC (OR, 2.30; 95% CI, 1.37 to 3.87; Pc, 0.051) combined
genotypes were observed. Altogether, these data indicate that
interaction among the 874T/A IFN- SNP and 597C/A, as
well 824C/T, IL-10 genotypes might have a role in suscepti-
bility to R. conorii infection.
DISCUSSION
In this study, the analysis of some relevant polymorphisms
for three cytokine genes profoundly involved in the immune
response against R. conorii allowed us some insight into the
protective or predisposing genotypes for this infection. Con-
cerning the TNF- locus, there is evidence supporting the fact
that a genetically determined production excess is associated
with the predisposition to infectious and autoimmune pathol-
ogies (22). In particular, an association between the 308A
allele and some infectious diseases, such as mucocutaneous
leishmaniasis, lepromatous leprosy, trachoma, hepatitis B, me-
ningococcal sepsis (30), and cerebral malaria (27), as well as
susceptibility to infectious pathogens of aged patients has been
demonstrated (11). We were unable to demonstrate an asso-
ciation between this TNF- polymorphism and MSF. These
findings do not exclude the possibility that other polymor-
phisms of TNF- genes might be involved in the predisposing
background for the clinical manifestations of MSF. In the MSF
patient group, we observed the reduction of the frequency of
the IFN- 874TT genotype. As previously demonstrated,
TH1 responses (which lead to the production of IFN-), re-
sponsible for the activation of the antimicrobial activity of
phagocytes as well as the intracellular killing of Rickettsia or-
ganisms by the endothelial cells and the TH1-dependent im-
munoglobulin G subclass production, are known to play a
central role in the anti-R. conorii response (7, 10, 15–17, 26,
29). The SNP at position 874 of the IFN- gene maps to a
putative nuclear factor-B (NF-B) binding site. The presence
of a T allele improves the NF-B binding efficiency and is
associated with raised IFN- expression in vitro (32, 33). In this
view, our data seem to suggest that a genetic predisposition to
produce high IFN- levels might have a protective effect for
the clinical outcome of the disease. Data from studies of in-
tracellular infectious diseases have demonstrated that a genet-
ically mediated reduction of the IFN- response is associated
with an increased susceptibility to a large arrays of pathogens
(2, 8, 36, 43). Recently, we reported, for the first time, that
874T allele frequency is reduced in subjects affected by
TABLE 2. Distribution of IFN- (874T/A) and IL-10 (1087A/G or 597C/A) SNP combined genotypes in 80 MSF patients
and 288 healthy controls
Genotypes Patients Controls
OR (95% CI) Pca
IFN- IL-10 n Frequency (%) n Frequency (%)
874TT 1087GG 1 1.25 17 5.90 0.20 (0.03–1.54) 1.00
1087GA 2 2.50 37 12.84 0.17 (0.04–0.74) 0.32
1087AA 1 1.25 11 3.80 0.32 (0.04–2.54) 1.00
597CC 1 1.25 41 14.20 0.08 (0.01–0.57) 0.060
597CA 2 2.50 22 7.60 0.31 (0.07–1.35) 1.00
597AA 1 1.25 2 0.70 1.83 (0.16–20.50) 1.00
874TA 1087GG 12 15.00 32 11.10 1.41 (0.69–2.89) 1.00
1087GA 24 30.00 62 21.53 1.562 (0.90–2.72) 1.00
1087AA 15 18.75 60 20.80 0.88 (0.47–1.65) 1.00
597CC 34 42.50 70 24.30 2.30 (1.37–3.87) 0.051
597CA 14 17.50 76 26.40 0.59 (0.31–1.12) 1.00
597AA 3 3.75 12 4.20 0.90 (0.25–3.26) 1.00
874AA 1087GG 4 5.00 18 6.25 0.79 (0.26–2.40) 1.00
1087GA 14 17.50 36 12.50 1.49 (0.76–2.91) 1.00
1087AA 7 8.75 15 5.20 1.75 (0.69–4.44) 1.00
597CC 8 10.00 41 14.20 0.67 (0.30–1.49) 1.00
597CA 15 18.75 12 4.20 5.31 (2.37–11.88) 0.0027
597AA 2 2.50 16 5.50 0.44 (0.10 to 1.94) 1.00
a Comparisons among the different combined genotype frequencies were performed by applying the nonparametric Mantel-Haenszel procedure. As multiple
comparisons were made, Bonferroni’s correction was applied to P values that were multiplied by the number of genotypes (27) involved in the analyses.
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chronic tuberculosis (25). This finding has been confirmed by
other groups (2, 35), and in a recent meta-analysis, the high
IFN--producing 874T allele has been shown to be nega-
tively associated with tuberculosis (31). Present data seem to
confirm the protective role of a genetically determined high
IFN- production against bacterial infections characterized by
an intracellular parasitism.
On the other hand, we have previously demonstrated that
the serum cytokine profile in MSF patients is characterized not
only by increasing proinflammatory cytokine levels (IFN-,
IL-6, and TNF-) but also by a significant increase of IL-10
levels (10, 26). In addition, de Sousa et al. (14) have recently
reported that the intralesional cytokine expression profile is
characterized by a mixed, proinflammatory and anti-inflamma-
tory response, as reflected by elevated levels of mRNA expres-
sion of IFN-, TNF-, and IL-10, in patients with MSF. Higher
intralesional expression of IFN- mRNA correlates with mild/
moderate MSF, suggesting that there is an IFN--mediated
reduction in bacterial load in these patients and that the si-
multaneous expression of higher levels of immunosuppressive
IL-10 mRNA may decrease responsiveness to IFN- (36).
The cytokine profile described above has been observed in
other intracellular bacteria-mediated infectious diseases, such
as brucellosis (3): IL-10 is associated with disease progression
and is involved in counteracting the IFN-- and TNF--medi-
ated activation of intracellular microbicidal mechanisms.
Accordingly, the results of the present study, indicating dif-
ferent distributions of IL-10 597C/A and IFN- 874T/A
combined genotypes in MSF patients and healthy controls,
suggest that a complex genetic background, i.e., IL-10 and
IFN- functional interaction, might be involved in susceptibil-
ity to MSF. In particular, the present data seem to suggest that
a genetic cytokine profile characterized by the combination of
874A- and 597C-positive genotypes might increase suscep-
tibility to MSF.
Actually, several investigators have shown that the presence
of the C allele in the 597 IL-10 promoter sequence, resulting
in an increased promoter activity, is associated with high levels
of IL-10 production (12, 34). More recently it has been re-
ported that IL-10 production levels depend on both the cells
and the antigenic stimulus involved (37). In particular, whole-
cell blood cultures, or partially or totally purified peripheral
blood mononuclear cells from 592C-positive subjects, stim-
ulated with lipopolysaccharides of gram-negative bacteria, are
able to produce higher levels of IL-10 (12, 34, 37). Lipopoly-
saccharides act through interaction with a complex receptor
machinery in which the Toll-like receptor 4 (TLR-4) is an
essential component.
As demonstrated in an animal experimental model (23),
dendritic cells expressing TLR-4 play a crucial role in stimu-
lating IFN- production and natural killer activity and are able
to limit rickettsial growth (23). In this view, it is intriguing that
we have recently reported that the 896A/G polymorphism at
the TLR-4 gene might be associated with MSF susceptibility
(4). Thus, our present and previous results indicate that a
potentially large number of genetic variants, with subtle effects
on the functions of specific immunological mediators, must be
taken into account in the regulation of the immune response
against R. conorii as well against other pathogens.
In conclusion, our data strongly suggest that a finely genet-
ically tuned cytokine production balance might play a crucial
role in regulating the interactions among pathogens and hosts,
probably influencing different outcomes, ranging from nonap-
parent or subclinical conditions to overt disease or fatal con-
sequences. In this view, the evaluation of cytokine genotypes
may be a useful tool for the identification of MSF patient
subgroups that may need a differently tailored antibiotic ther-
apy schedule.
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